Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $55.50
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 15, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Mccartney John | director | A-Award | 48 | — |
Daily · Wilder smoothing
| Mizuho |
| maintain |
| Outperform |
| Outperform |
| Oct 15, 26 | UBS | maintain | Buy | Buy |
| Sep 29, 26 | Jefferies | maintain | Buy | Buy |
| Sep 23, 26 | Citigroup | maintain | Buy | Buy |
| Sep 17, 26 | Stephens & Co. | maintain | Overweight | Overweight |
| Sep 14, 26 | UBS | maintain | Buy | Buy |
| Aug 19, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Aug 17, 26 | Barclays | maintain | Overweight | Overweight |
| Jul 28, 26 | Citigroup | maintain | Buy | Buy |
| Oct 1, 26 |
| Rice Daniel J. Iv |
| director |
| A-Award |
| 592 |
| — |
| Aug 14, 26 | Rice Toby Z. | director, officer: PRESIDENT & CEO | S-Sale | 175,328 @ $55.03 | $9.65M |
| Jul 27, 26 | Bolen J.E.B. | officer: EVP OPERATIONS | F-InKind | 3,904 @ $52.00 | $203.0K |
| Jul 27, 26 | Fenton Sarah | officer: EVP UPSTREAM | F-InKind | 3,904 @ $52.00 | $203.0K |
| Jul 24, 26 | Knop Jeremy | officer: CHIEF FINANCIAL OFFICER | F-InKind | 1,011 @ $53.03 | $53.61K |
| Jul 1, 26 | Mccartney John | director | A-Award | 44 | — |
| Jul 1, 26 | Rice Daniel J. Iv | director | A-Award | 541 | — |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 63.13 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 89.42 | Oscillator | Sell |
| Williams %R (14) | -10.78 | Oscillator | Sell |
| MACD (12, 26, 9) | 0.74 (Hist 0.36) | Oscillator | Strong Buy |
| Average Directional Index (14) | 17.39 (+DI 28.1 / -DI 19.3) | Trend | Neutral |
| EMA 20 | 53.31 | MA | Strong Buy |
| SMA 20 | 52.49 | MA | Strong Buy |
| EMA 50 | 52.92 | MA | Strong Buy |
| SMA 50 | 53.01 | MA | Strong Buy |
| SMA 200 | 55.47 | MA | Buy |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Oct 13, 2026 | 2026-10-13 16:20:10 | View |
| 8-K | Oct 7, 2026 | 2026-10-07 16:16:05 | View |
| 4 | Oct 5, 2026 | 2026-10-05 16:05:14 | View |
| 4 | Oct 5, 2026 | 2026-10-05 16:05:10 | View |
| 4 | Aug 18, 2026 | 2026-08-18 16:15:09 | View |
| 144 | Aug 14, 2026 | 2026-08-14 16:04:16 | View |
| 4 | Jul 28, 2026 | 2026-07-28 18:30:09 | View |
| 4 | Jul 28, 2026 | 2026-07-28 18:30:07 | View |
| 4 | Jul 28, 2026 | 2026-07-28 18:30:06 | View |
| 10-Q | Jul 22, 2026 | 2026-07-22 16:16:23 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | EQT | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 12.2x | 25.6x · sector 14.8x | Discount |
| Forward P/E (FY26E) | 14.1x | EPS est. 3.94 | Elevated |
| Price / Book | 1.4x | 1.1x | Elevated |
| Price / Sales | 3.7x | 2.6x | Elevated |
| EV / EBITDA | 5.8x | 11.3x | Discount |
| Return on equity | 11.7% | — | Healthy |
| Gross margin | 68.4% | 38.5% | Above hist. |
| Debt / Equity | 0.22 | 0.45 | Conservative |
| Piotroski / Altman Z | 7/9 | Z 2.33 | Grey zone |
Discounted cash flow model
FY2025 · 10-K disclosure
Stock news · updated daily
EQT heads into Q3 2026 earnings with estimates pointing to lower profits as weaker natural gas prices weigh on results.
The Undercovered Dozen spotlights 12 lesser-followed stocks featured on Seeking Alpha from Oct. 10 to Oct. 16. This curated series aims to surface overlooked investment ideas and foster discussion among sophisticated investors. Readers are encouraged to engage, debate, and share additional undercovered stock ideas in the community.
VENLO, Netherlands & AMSTERDAM--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) and the EQT XI fund (“EQT Private Equity”) today announced an agreement under which Crown NL Bidco B.V. (the “Bidder”) announced its decision to make an all-cash voluntary public takeover offer for the acquisition of all outstanding QIAGEN shares at €46.50 per share (the “Takeover Offer”). The Bidder is a holding company indirectly controlled by EQT XI fund with f.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 21, 2026 | 0.41 | 0.39 | Miss -5.4% | $1.81B |
| Apr 21, 2026 | 2.08 | 2.33 | Beat 12.0% | $3.38B |
| Feb 17, 2026 | 0.76 | 0.90 | Beat 18.4% | $2.39B |
| Oct 21, 2025 | 0.36 | 0.52 | Beat 43.8% | $1.82B |
| Jul 22, 2025 | 0.42 | 0.45 | Beat 7.3% | $2.56B |
| Apr 22, 2025 | 1.03 | 1.18 | Beat 14.6% | $2.42B |